HLS Therapeutics Inc. (TSX:HLS)

Canada · Delayed Price · Currency is CAD

4.400

0.00 (0.00%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	55.50M	56.62M	63.07M	61.47M	60.01M
Pharmaceuticals Growth	-1.98%	-10.23%	2.61%	2.43%	6.95%
Total	55.50M	56.62M	63.07M	61.47M	60.01M
Total Growth	-1.98%	-10.23%	2.61%	2.43%	6.95%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Canada	42.47M	42.65M	39.29M	37.02M	34.69M
Canada Growth	-0.42%	8.54%	6.13%	6.71%	17.95%
United States	12.56M	13.19M	18.47M	19.56M	20.17M
United States Growth	-4.76%	-28.61%	-5.59%	-3.01%	-20.90%
Rest of World	478.00K	788.00K	5.31M	4.88M	5.15M
Rest of World Growth	-39.34%	-85.17%	8.79%	-5.09%	330.54%
Total	55.50M	56.62M	63.07M	61.47M	60.01M
Total Growth	-1.98%	-10.23%	2.61%	2.43%	6.95%

Source: S&P Global Market Intelligence.